Truvian Sciences President and CEO Jeff Hawkins to Speak Among Leaders of Nation’s Most Innovative Labs at The Dark Intelligence Group’s Executive War College Conference

NEW ORLEANS--()--Truvian Sciences President and CEO Jeff Hawkins joins leaders of the nation’s most innovative labs to share new technologies and approaches to improve patient outcomes.


The Dark Intelligence Group’s Executive War College Conference on Laboratory & Pathology Management



General Session — Wednesday, April 27, 2022 at 11 a.m.

Rethinking the Clinical Laboratory Test Value Chain: Using New Technologies and New Approaches to Lower Costs, Speed Time-to-Answer, and Contribute to Improved Patient Outcomes


General Session Panel — Wednesday, April 27, 2022 at 4:45 p.m. CDT

Thinking Strategically: Spotting Opportunities Created by the Evolution of the Healthcare Value-Based Reimbursement, and New Technologies



Hyatt Regency

601 Loyola Avenue

New Orleans, LA 70113



Jeff Hawkins, President and CEO of Truvian Sciences



Michael Sullivan,

For more information or to view the full agenda, visit:

About Truvian Sciences

Truvian is a healthcare company at the intersection of diagnostics and consumer technology. Its automated benchtop system is being developed to produce lab-accurate results for a full-suite of health tests using a small sample of blood. Powered by patented technologies and intelligent integration, Truvian’s system delivers a convenient and affordable alternative to off-site labs, providing immediate insights to inform healthcare decisions. Truvian was founded by individuals with deep domain experience in healthcare, diagnostics, and consumer technology. Today, the team has expanded to include top scientists, engineers, and healthcare business leaders — each bringing specialized expertise to drive Truvian’s mission of making routine health testing convenient, affordable, and actionable.


Michael Sullivan,

Social Media Profiles


Michael Sullivan,